Dissecting the Molecular Role of TBX1 in the Context of Human Pharyngeal Endoderm Development

解析 TBX1 在人咽内胚层发育中的分子作用

基本信息

  • 批准号:
    10442889
  • 负责人:
  • 金额:
    $ 39.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-01 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY 22q11.2 Deletion Syndrome (22q11.2DS), the most common of the microdeletion syndromes, is caused by hemizygous loss of 0.7-3 Mb of DNA on chromosome 22 and results in a constellation of clinical phenotypes. The core phenotype originates from disrupted development of the pharyngeal apparatus. Particularly affected are the second heart field-dependent heart structures, great vessels, parathyroids, thymus, and lower craniofacial and face muscles. Although approximately 50 genes may be deleted, it is the haploinsufficiency of the transcription factor TBX1 that recapitulates most of the critical phenotype associated with 22q11.2DS. Genetic and developmental mouse studies have established that TBX1 is critical for typical development of the pharyngeal endoderm, a transient anatomical structure necessary for development of the thymus, parathyroids, and 4th pharyngeal arch arteries. Despite this central role, very little is known regarding the molecular mechanisms by which TBX1 functions in the pharyngeal endoderm. While a handful of studies have attempted to study the role of TBX1 in human cells, the cell types they have been conducted in are not representative of the appropriate developmental stage where and when TBX1 plays its critical role. To date, an effort to integrate all the critical genes into a pharyngeal endoderm or 4th pharyngeal arch arteries network has not been attempted, particularly in human cells. This R01 leverages recent development of an in vitro model which faithfully mimics the formation and progression of human pharyngeal endoderm, thereby providing an unprecedented opportunity to tease out the functions of TBX1 in its physiological context. Specifically, this model will be used to identify the transcriptional targets and partners of TBX1 (Aim1), investigate the role of TBX1 as epigenetic regulator of the human pharyngeal endoderm (Aim2), and mechanistically investigate newly discovered putative regulatory regions of the TBX1 locus (Aim3). The overarching hypothesis is that TBX1 is at the center of a Gene Regulatory Network critical for both the formation and maturation of the pharyngeal endoderm and the morpho-patterning of the surrounding mesoderm and neural crest cells. The proposed work is expected to identify the molecular mechanism at the basis of TBX1 haploinsufficiency and identify pathways which could be rescued through pharmacological intervention. Dissection of the epigenetic and molecular machinery responsible for pharyngeal endoderm formation will be instrumental in informing the generation of cell therapies for 22q11.2DS.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vittorio Sebastiano其他文献

Vittorio Sebastiano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vittorio Sebastiano', 18)}}的其他基金

Dissecting the Molecular Role of TBX1 in the Context of Human Pharyngeal Endoderm Development
解析 TBX1 在人咽内胚层发育中的分子作用
  • 批准号:
    10615234
  • 财政年份:
    2022
  • 资助金额:
    $ 39.35万
  • 项目类别:
Single Step Strategy for the Therapeutic Reprogramming in Epidermolysis Bullosa Patients
大疱性表皮松解症患者治疗性重编程的一步策略
  • 批准号:
    9475196
  • 财政年份:
    2017
  • 资助金额:
    $ 39.35万
  • 项目类别:
Single Step Strategy for the Therapeutic Reprogramming in Epidermolysis Bullosa Patients
大疱性表皮松解症患者治疗重编程的一步策略
  • 批准号:
    9317254
  • 财政年份:
    2017
  • 资助金额:
    $ 39.35万
  • 项目类别:
Animal Tumor Models
动物肿瘤模型
  • 批准号:
    10411090
  • 财政年份:
    2007
  • 资助金额:
    $ 39.35万
  • 项目类别:
Animal Tumor Models
动物肿瘤模型
  • 批准号:
    10626972
  • 财政年份:
    2007
  • 资助金额:
    $ 39.35万
  • 项目类别:
Animal Tumor Models
动物肿瘤模型
  • 批准号:
    9113308
  • 财政年份:
  • 资助金额:
    $ 39.35万
  • 项目类别:

相似国自然基金

22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
22q11.2微缺失综合症中T盒转录因子Tbx1与信号接头蛋白Crkl遗传相互作用致肺动脉发育不良缺陷的机制研究
  • 批准号:
    81170153
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
基于染色体22q11.2候选基因与腭心面综合征表型的分子诊断研究
  • 批准号:
    81070813
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
无22q11.2区基因微缺失的心脏圆锥动脉干畸形患者中新TBX1突变体蛋白的功能研究
  • 批准号:
    81070135
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
染色体22q11.2区域泌尿系统畸形关键致病基因的克隆与鉴定
  • 批准号:
    30571867
  • 批准年份:
    2005
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目

相似海外基金

成人期へtransitionする22q11.2欠失症候群患者の移行支援プログラムの構築
为 22q11.2 缺失综合征患者过渡到成年期建立过渡支持计划
  • 批准号:
    24K13915
  • 财政年份:
    2024
  • 资助金额:
    $ 39.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome
一种工程水凝胶平台,可提高 22q11.2 缺失综合征多器官疾病模型的神经类器官再现性
  • 批准号:
    10679749
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
Outcomes and disease burden in a model of young adult multimorbidity
年轻成人多重病模型的结果和疾病负担
  • 批准号:
    479042
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
    Operating Grants
重複障害を呈する医療的ケア児と家族の移行期における意思決定支援のPPI型研究
多重残疾儿童及其家庭过渡期决策支持的PPI型研究
  • 批准号:
    23H02834
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
22q11.2欠失症候群との網羅的な比較検討によるファロー四徴症での遺伝子異常の解明
与22q11.2缺失综合征综合比较阐明法洛四联症遗传异常
  • 批准号:
    23K08237
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating abnormalities in top-down cortical processing and behavior in a model of the 22q11.2 deletion
研究 22q11.2 缺失模型中自上而下的皮质处理和行为的异常
  • 批准号:
    10649058
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
Phenotypic convergence at mitochondria in copy number variant disorders
拷贝数变异性疾病中线粒体的表型趋同
  • 批准号:
    10723885
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
Neurodevelopmental defects of the thalamocortical pathway as a convergent feature of psychiatric disorders
丘脑皮质通路的神经发育缺陷是精神疾病的共同特征
  • 批准号:
    10655225
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
Improving Genetic Diagnosis for African Ancestry Populations
改善非洲血统人群的基因诊断
  • 批准号:
    10736833
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
The schizophrenia-associated 3q29 deletion: genetic architecture of behavioral phenotypes
精神分裂症相关的 3q29 缺失:行为表型的遗传结构
  • 批准号:
    10579244
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了